An unexpected isolate of Hafnia alvei with reduced susceptibility to cefoxitin

References 

1. Dunne WM, Hardin DJ. Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp. J Clin Microb. 2005;43(12):5945–5949
2. Girlich D, Naas T, Bellais S, Poirel L, Karim A, Nordmann P. Biochemical–genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei. Antimicrob Agents Chemother. 2000;44(6):1470–1478
   • MEDLINE
   • CrossRef
3. Gupta V. An update on newer β-lactamases. Indian J Med Res. 2007;126:417–427
4. Janda JM, Abbott SL. The genus Hafnia: from soup to nuts. Clin Microb Rev. 2006;19(1):12–18
5. Lister PD, Gardner VM, Sanders CC. Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin. Antimicrob Agents Chemother. 1999;43:882–889
   • MEDLINE
6. National Committee for Clinical Laboratory Standards . Performance standards for antimicrobial disk susceptibility tests. Approved standard M2–A8. Wayne, PA: National Committee for Clinical Laboratory Standards; 2003;
7. National Committee for Clinical Laboratory Standards . Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. NCCLS document M7-A6 6th ed.. Wayne, PA: National Committee for Clinical Laboratory Standards; 2003;
8. She D, Liu Y. The expression of AmpC and extended-spectrum β-lactmases among clinical isolates of Enterobacter cloacae and its impact on antibiotics susceptibility. Zhonghua Yi Xue Za Zhi. 2002;82(19):1355–1358
   • MEDLINE
9. Thomson KS, Sanders CC, Washington JA. Ceftazidime resistance in Hafnia alvei. Antimicrob Agents Chemother. 1993;37(6):1375–1376
   • MEDLINE